ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Grants Astellas/Pfizer’s XTANDI® Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer
August 23, 2019Astellas Pharma Inc. and Pfizer Inc. have announced that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) to ... -
Sanofi's controversial Dengvaxia picks up FDA priority review
November 09, 2018Sanofi has weathered controversy with its world-first dengue vaccine, Dengvaxia, but the company is pressing ahead, and on Tuesday said the FDA had not only accepted
Pharma Sources Insight January 2025
